Reports and Insights (R&I) has published a new report titled, “Medical Polymer Splint Market: Opportunity Analysis and Future Assessment 2020-2028”
Global Medical Polymer Splint Market, by Product Type (Glass fiber, Polyurethane, Resin, and Other), by Application (Hospitals, Clinical, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2020 and 2028.
As per the report, the rise in the geriatric and obese population and developing serious orthopedic conditions in them is majorly contributing to the growth of the global medical polymer splints market. The medical polymer splints are used to protect and support fractured joints and bones. The increasing prevalence of serious medical conditions like osteoporosis in which bones become weak and risk of broken bones is increased and such other related ailments is also boosting the medical polymer splints market.
Also, according to the World Health Organization (WHO), 2013, around 28.2% of the global population aged 60 years and above, suffered from osteoarthritis with an estimated 80% people recorded with mobility handicaps. Additionally, in recent past years, the fast-moving vehicles on the road has resulted in a huge number of road accidents and serious injuries, which accelerated the growth of the medical polymer splints market. Moreover, the innovation and technological advancements in medical tools and equipment has led to the faster growth of the global medical polymer splints market as these medical polymer splints are made from plaster or fiberglass, and they can be easily molded to the shape of injured legs and arms.
Notably, these medical polymer splints are designed in a manner to provide practical support to soft tissue injuries and bone fractures, granting improved mobility and flexibility with partially-solid form, thus decreasing immobilization-related problems such as joint stiffness, and conclusively shortening the healing process. Attributable to all such features and benefits, the medical polymer splints market is projected to witness a significant growth in the coming years.
Furthermore, the high demand of orthopedic medical equipment such as wrist splints, leg, traction and vacuum splints among the consumers is also propelling the medical polymer splints market. The medical polymer splints are conducive to blood circulation and thus, its demand automatically increases in the global market, ultimately boosting the global medical polymer splints market. In addition to that, the unhealthy and busy lifestyle of the consumers is also a major driver augmenting the growth of the global medical polymer splints market. However, the development of compartment syndrome, pressure sores, and thermal injuries during the splinting process and formation of bacterial and fungal infections occurring underneath the medical polymer splints are the barriers restraining the medical polymer splints market growth.
R&I Study identifies some of the key participating players in medical polymer splints market globally are Glaxon Pharma, Tuoren, Performance Health, Topcare Biotech, AdvaCare Pharma, Jiangsu Maibang Biotechnology, Shandong Haidi Ke Biotechnology, Shaanxi Yuanguang High Technology, Jinan Tasite Biotechnology, Anhui Ankang Health Materials, and Wuxi Sandy.
Reports and Insights (R&I) is committed to provide deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At R&I we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
Reports and Insights (R&I)
For Sales Queries: email@example.com
For New Topics and Other Info: firstname.lastname@example.org